Approvals/TGA/CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial

Approved

STANDARD

CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial

Cipla Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: f64dd523985366ac
Product Name: CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial
Artg Id: 318837
Artg Name: CIPLA MEDROXYPROGESTERONE medroxyprogesterone acetate 150 mg/1 mL injection suspension vial
Sponsor: Cipla Australia Pty Ltd
Company Detail Path: /organization/cipla-australia-pty-ltd
Artg Date: 2020-05-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

f64dd523985366ac

Type

Standard